Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

141. Efficacy, safety and treatment discontinuation of pharmacological interventions for adults with ADHD: a meta-analysis and metaregression study

Efficacy, safety and treatment discontinuation of pharmacological interventions for adults with ADHD: a meta-analysis and metaregression study Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

142. Meta-analysis of organizational skills interventions for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Meta-analysis of organizational skills interventions for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

143. Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs) [Cochrane Protocol]

Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs) [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

144. A systematic review of attention deficit hyperactivity disorder (ADHD) and mathematical ability: current findings and future implications

A systematic review of attention deficit hyperactivity disorder (ADHD) and mathematical ability: current findings and future implications Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

145. A systematic review of video-modelling interventions for children with ADHD: a meta-synthesis

A systematic review of video-modelling interventions for children with ADHD: a meta-synthesis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2015 PROSPERO

146. Miscellaneous: Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation

Miscellaneous: Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation Article Text Electronic

2015 Evidence-Based Mental Health

147. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. (PubMed)

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Symptoms of attention deficit hyperactivity disorder (ADHD), diagnosed mainly in children, often persist into adulthood. Adults in this group have a high rate of other psychiatric problems and functional difficulties in a number of key areas such as academic achievement, interpersonal relationships, and employment. Although the usefulness of immediate-release methylphenidate in children has been (...) authors of recently published trials.We included all randomized trials comparing immediate-release methylphenidate versus placebo in participants aged 18 years or older with ADHD. We excluded trials conducted on subpopulations of adults with ADHD such as adults with both ADHD and substance dependence.Two review authors independently selected trials, extracted data, and assessed trial risk of bias. We contacted authors of trials to ask for additional and missing data. For dichotomous outcomes, we

2014 Cochrane

148. ADHD: medication and society

ADHD: medication and society ADHD: medication and society ADHD: medication and society Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. ADHD: medication and society. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2014/19. 2014 Final publication URL Indexing Status Subject

2014 Health Technology Assessment (HTA) Database.

149. Management of ADHD in preschool-aged children

Management of ADHD in preschool-aged children Management of ADHD in preschool-aged children Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Management of ADHD in preschool-aged children View/ Open Date 2013-09 Format Metadata Abstract Behavior therapy interventions, such as parent training, are first-line treatment (...) for ADHD in preschool-aged children (three to five years of age). (Strength of Recommendation [SOR]: B, based on a systematic review of a small number of heterogeneous randomized controlled trials [RCTs].) Medication is an option for children with moderate to severe ADHD if behavior therapy has not been effective and if the benefits outweigh the harms. (SOR: B, based on a systematic review of a small number of heterogeneous RCTs.) Alternative therapies, such as elimination diets, have limited evidence

2014 Clinical Inquiries

150. Atomoxetine (Strattera) - adults with attention deficit hyperactivity disorder (ADHD)

Atomoxetine (Strattera) - adults with attention deficit hyperactivity disorder (ADHD) All Wales Medicines Strategy Group (AWMSG) - atomoxetine (Strattera) | | Appraisal information Search and reports atomoxetine (Strattera®) Reference No. 1361 Publication date: 27/02/2014 Last review date: 01/12/2016 Appraisal information atomoxetine (Strattera®) 10 mg capsule atomoxetine (Strattera®) 18 mg capsule atomoxetine (Strattera®) 25 mg capsule atomoxetine (Strattera®) 40 mg capsule atomoxetine (...) NHS Wales for the initiation of treatment in adults with attention deficit hyperactivity disorder (ADHD). Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria or the guidelines in International Classification of Mental and Behavioural Disorders (ICD). In adults, the presence of symptoms of ADHD

2014 All Wales Medicines Strategy Group

151. Comparing executive function between adults ADHD patients with and without cocaine and/or crack addiction: a systematic review and meta-analysis

Comparing executive function between adults ADHD patients with and without cocaine and/or crack addiction: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2014 PROSPERO

152. Systematic review of the relationship between the symptoms of Attention Deficit Hyperactivity Disorder (ADHD)/Hyperkinetic Disorder (HD) and video game play

Systematic review of the relationship between the symptoms of Attention Deficit Hyperactivity Disorder (ADHD)/Hyperkinetic Disorder (HD) and video game play Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2014 PROSPERO

153. Systematic review of occupational therapy and other psycho social interventions for children with Attention Deficit and Hyperactivity disorder (ADHD)

Systematic review of occupational therapy and other psycho social interventions for children with Attention Deficit and Hyperactivity disorder (ADHD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2014 PROSPERO

154. Atomoxetine for children and adolescents with attention deficit hyperactivity disorder (ADHD)

Atomoxetine for children and adolescents with attention deficit hyperactivity disorder (ADHD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2014 PROSPERO

155. Atomoxetine is a second-line medication treatment option for ADHD

Atomoxetine is a second-line medication treatment option for ADHD Atomoxetine is a second-line medication treatment option for ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Atomoxetine is a second-line medication treatment option for ADHD Article Text Pharmacological interventions Atomoxetine is a second-line medication treatment option for ADHD Jaswinder K Ghuman 1 , Shari L Hutchison 2 Statistics from Altmetric.com What

2014 Evidence-Based Mental Health

156. Medication reduces crash risk among men with ADHD (Full text)

Medication reduces crash risk among men with ADHD Medication reduces crash risk among men with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Medication reduces crash risk among men with ADHD Article Text Causes and risk factors Medication reduces crash risk among men with ADHD Flaura Koplin Winston 1 , Daniel Romer 2 Statistics from Altmetric.com What is already known on this topic? Safe driving requires ‘situation awareness’, a combined

2014 Evidence-Based Mental Health

157. Autism traits may be more prevalent in ADHD than previously reported

Autism traits may be more prevalent in ADHD than previously reported Autism traits may be more prevalent in ADHD than previously reported | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Autism traits may be more prevalent in ADHD than previously reported Article Text Prevalence, assessment and diagnosis Autism traits may be more prevalent in ADHD than previously reported Kevin Antshel Statistics from Altmetric.com What is already known

2014 Evidence-Based Mental Health

158. Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders

Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders Stimulant medication for ADHD not associated with subsequent substance use disorders | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Stimulant medication for ADHD not associated with subsequent substance use disorders Article Text Aetiology Systematic review with meta-analysis Stimulant medication for ADHD

2014 Evidence-Based Medicine

159. Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence

Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence Article Text Causes Review: no evidence that stimulant

2014 Evidence-Based Mental Health

160. Review: recommendations for the assessment and management of sleep disorders in ADHD

Review: recommendations for the assessment and management of sleep disorders in ADHD Review: recommendations for the assessment and management of sleep disorders in ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: recommendations for the assessment and management of sleep disorders in ADHD Article Text Outcomes Review: recommendations for the assessment and management of sleep disorders in ADHD Statistics from

2014 Evidence-Based Mental Health